1. Home
  2. CVI vs APLS Comparison

CVI vs APLS Comparison

Compare CVI & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVR Energy Inc.

CVI

CVR Energy Inc.

HOLD

Current Price

$21.10

Market Cap

3.1B

Sector

Energy

ML Signal

HOLD

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

HOLD

Current Price

$22.25

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVI
APLS
Founded
1906
2009
Country
US
US
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.7B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
CVI
APLS
Price
$21.10
$22.25
Analyst Decision
Strong Sell
Buy
Analyst Count
3
20
Target Price
$26.67
$32.16
AVG Volume (30 Days)
1.1M
2.3M
Earning Date
05-20-2026
04-02-2026
Dividend Yield
N/A
N/A
EPS Growth
350.00
64.04
EPS
0.27
0.65
Revenue
$7,162,000,000.00
$781,367,000.00
Revenue This Year
N/A
$31.31
Revenue Next Year
N/A
N/A
P/E Ratio
$83.37
$34.22
Revenue Growth
N/A
97.02
52 Week Low
$15.10
$16.10
52 Week High
$41.67
$30.48

Technical Indicators

Market Signals
Indicator
CVI
APLS
Relative Strength Index (RSI) 35.04 47.24
Support Level $22.60 $21.30
Resistance Level $23.63 $22.41
Average True Range (ATR) 1.08 1.05
MACD -0.01 -0.02
Stochastic Oscillator 32.71 32.86

Price Performance

Historical Comparison
CVI
APLS

About CVI CVR Energy Inc.

CVR Energy Inc is a holding company that engages in petroleum refining and nitrogen fertilizer manufacturing through its subsidiaries. Subsidiaries include several complex, full-coking crude oil refineries, along with a crude oil gathering system, pipelines and storage tanks, and marketing and supply. The company's refineries can process blends of a variety of crude oil ranging from heavy sour to light sweet crude oil. Crude oil for CVR's refineries is supplied through its wholly-owned gathering system and pipeline. From its refineries, CVR supplies products through tanker trucks directly to customers located in close geographic proximity and customers at throughput terminals. The company's customers include retailers, railroads, and farm cooperatives.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: